Cleerly

Cleerly is a comprehensive, AI-driven platform that quantifies and assesses coronary artery disease (CAD) to deliver clinically actionable insights through a web-based solution. Our software quantifies atherosclerosis by measuring plaque volume, composition, length, and location, evaluates stenosis severity in both 2D (diameter and area) and 3D (lumen and vessel volume), with a workflow for determ

02/01/2026

❤️ February marks , when the prevention, detection, and care of heart disease steps into the spotlight.

But heart disease isn’t a month-long issue.

According to the CDC, it has remained the leading cause of death in the United States for over 100 years.

While awareness of the most common symptoms and risk factors has improved, heart disease doesn’t always start with symptoms, and physicians' ability to see plaque is the missing piece.

Research shows high-risk soft plaque is the primary driver of disease. However, today’s standard of care often overlooks this silent culprit.

That’s why at Cleerly, Heart Month isn’t just one month; it’s every month.

It’s a philosophy, woven into every conversation and innovation, because creating a new standard of care begins with seeing plaque and understanding risk earlier. 🔍🫀

Source: https://bit.ly/4teVhfU